Table 4:

Differences in clinical and laboratory findings between VER and non-VER patients after 3 months of TRB treatment.

 VERNon-VERP
N1720
Male/female13/413/7.45
Age (years)45.5 ± 13.7352.36 ± 12.95.2
SBP (mmHg) T3128.33 ± 10.41126.5 ± 8.18.84
DBP (mmHg) T376.67 ± 5.7776 ± 10.49.98
Smoking habits (n)1115.97
BMI (kg/m2)25.32 ± 2.9826.00 ± 3.86.55
Statin administration (n)818.23
Time since diagnosis (months)29.41 ± 6.9665.37 ± 17.64.05
eGFR Tbx (mL/min/1.73 m2)70.6 ± 24.7452.46 ± 16.35.05
eGFR T0 (mL/min/1.73 m2)67.96 ± 21.9848.05 ± 19.24.01
Uprot Tbx (g/24 h)3.64 ± 2.372.15 ± 1.24.05
Uprot T0 (g/24 h)2.67 ± 1.612.96 ± 1.69.66
UPCR Tbx (g/g)3.86 ± 0.681.83 ± 1.14.02
UPCR T0 (g/g)2.26 ± 0.541.89 ± 0.2.66
 VERNon-VERP
N1720
Male/female13/413/7.45
Age (years)45.5 ± 13.7352.36 ± 12.95.2
SBP (mmHg) T3128.33 ± 10.41126.5 ± 8.18.84
DBP (mmHg) T376.67 ± 5.7776 ± 10.49.98
Smoking habits (n)1115.97
BMI (kg/m2)25.32 ± 2.9826.00 ± 3.86.55
Statin administration (n)818.23
Time since diagnosis (months)29.41 ± 6.9665.37 ± 17.64.05
eGFR Tbx (mL/min/1.73 m2)70.6 ± 24.7452.46 ± 16.35.05
eGFR T0 (mL/min/1.73 m2)67.96 ± 21.9848.05 ± 19.24.01
Uprot Tbx (g/24 h)3.64 ± 2.372.15 ± 1.24.05
Uprot T0 (g/24 h)2.67 ± 1.612.96 ± 1.69.66
UPCR Tbx (g/g)3.86 ± 0.681.83 ± 1.14.02
UPCR T0 (g/g)2.26 ± 0.541.89 ± 0.2.66

Data are presented as mean ± standard deviation or n.

SBP, systolic BP; DBP, diastolic BP.

Table 4:

Differences in clinical and laboratory findings between VER and non-VER patients after 3 months of TRB treatment.

 VERNon-VERP
N1720
Male/female13/413/7.45
Age (years)45.5 ± 13.7352.36 ± 12.95.2
SBP (mmHg) T3128.33 ± 10.41126.5 ± 8.18.84
DBP (mmHg) T376.67 ± 5.7776 ± 10.49.98
Smoking habits (n)1115.97
BMI (kg/m2)25.32 ± 2.9826.00 ± 3.86.55
Statin administration (n)818.23
Time since diagnosis (months)29.41 ± 6.9665.37 ± 17.64.05
eGFR Tbx (mL/min/1.73 m2)70.6 ± 24.7452.46 ± 16.35.05
eGFR T0 (mL/min/1.73 m2)67.96 ± 21.9848.05 ± 19.24.01
Uprot Tbx (g/24 h)3.64 ± 2.372.15 ± 1.24.05
Uprot T0 (g/24 h)2.67 ± 1.612.96 ± 1.69.66
UPCR Tbx (g/g)3.86 ± 0.681.83 ± 1.14.02
UPCR T0 (g/g)2.26 ± 0.541.89 ± 0.2.66
 VERNon-VERP
N1720
Male/female13/413/7.45
Age (years)45.5 ± 13.7352.36 ± 12.95.2
SBP (mmHg) T3128.33 ± 10.41126.5 ± 8.18.84
DBP (mmHg) T376.67 ± 5.7776 ± 10.49.98
Smoking habits (n)1115.97
BMI (kg/m2)25.32 ± 2.9826.00 ± 3.86.55
Statin administration (n)818.23
Time since diagnosis (months)29.41 ± 6.9665.37 ± 17.64.05
eGFR Tbx (mL/min/1.73 m2)70.6 ± 24.7452.46 ± 16.35.05
eGFR T0 (mL/min/1.73 m2)67.96 ± 21.9848.05 ± 19.24.01
Uprot Tbx (g/24 h)3.64 ± 2.372.15 ± 1.24.05
Uprot T0 (g/24 h)2.67 ± 1.612.96 ± 1.69.66
UPCR Tbx (g/g)3.86 ± 0.681.83 ± 1.14.02
UPCR T0 (g/g)2.26 ± 0.541.89 ± 0.2.66

Data are presented as mean ± standard deviation or n.

SBP, systolic BP; DBP, diastolic BP.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close